pasireotide


SMILES NCCCC[C@@H]1NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H]2N(C(=O)[C@@H](NC(=O)[C@@H](NC1=O)Cc1ccc(cc1)OCc1ccccc1)Cc1ccccc1)C[C@@H](C2)OC(=O)NCCN)c1ccccc1)Cc1c[nH]c2c1cccc2
InChIKey VMZMNAABQBOLAK-DBILLSOUSA-N
Sequence XXWKYF

Chemical properties

Hydrogen bond acceptors 11
Hydrogen bond donors 9
Rotatable bonds 17
Molecular weight (Da) 1046.5

Drug properties

Molecular type Peptide
Physiological/Surrogate Surrogate
Approved drug Yes

Bioactivities

Receptor Activity Source
GTP Uniprot Species Family Class Type Min Avg Max Database
SST1 SSR1 Human Somatostatin A pKi 8.2 8.2 8.2 ChEMBL
SST2 SSR2 Human Somatostatin A pKi 9.0 9.0 9.0 ChEMBL
SST3 SSR3 Human Somatostatin A pKi 9.1 9.1 9.1 ChEMBL
SST5 SSR5 Human Somatostatin A pKi 9.9 9.9 9.9 ChEMBL
Receptor Activity Source
GTP Uniprot Species Family Class Type Min Avg Max Database
SST2 SSR2 Rat Somatostatin A pEC50 7.76 7.01 9.07 Guide to Pharmacology
SST1 SSR1 Human Somatostatin A pIC50 8.0 8.0 8.0 Guide to Pharmacology
SST2 SSR2 Human Somatostatin A pIC50 9.0 9.0 9.0 Guide to Pharmacology
SST3 SSR3 Human Somatostatin A pIC50 8.8 8.8 8.8 Guide to Pharmacology
SST5 SSR5 Human Somatostatin A pIC50 9.8 9.8 9.8 Guide to Pharmacology
SST2 SSR2 Rat Somatostatin A pEC50 8.04 8.04 8.04 Drug Central
SST1 SSR1 Human Somatostatin A pIC50 8.1 8.1 8.1 Drug Central
SST2 SSR2 Human Somatostatin A pIC50 8.05 8.05 8.05 Drug Central
SST3 SSR3 Human Somatostatin A pIC50 8.06 8.06 8.06 Drug Central
SST5 SSR5 Human Somatostatin A pIC50 8.01 8.01 8.01 Drug Central